Bavarian Nordic Secures New Procurement Framework Contract from the European Commission to Enhance Readiness for Smallpox and Mpox
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 31 2025
0mins
Source: Yahoo Finance
New Framework Contract: Bavarian Nordic has secured a new contract with the European Commission’s HERA to supply up to 8 million doses of its MVA-BN smallpox/mpox vaccine over the next four years, replacing a previous agreement from 2022.
Expanded Access: The agreement now includes participation from 20 EU member states and other European countries, ensuring broader access to the vaccine, with an initial commitment of 1.1 million doses, including 750,000 expected to be delivered in 2026.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
